Article
VEXAS syndrome: a comprehensive review of pathogenesis, clinical spectrum, and therapeutic strategies.
Lancet (London, England) - 7 Feb 2026
Groarke Emma M, Turturice Benjamin, Patel Bhavisha A, Quinn Kaitlin A, Fike Alice, Grayson Peter C
Abstract excerpt
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is a monogenic disease of adulthood characterised by treatment-refractory systemic inflammation and progressive bone marrow failure. VEXAS syndrome is caused by acquired mutations in the UBA1 gene that are restricted to haematopoietic cells. Men aged 50 years or older are particularly susceptible to VEXAS syndrome, with prevalence estimates...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
